| Date Filed | Type | Description |
| 05/04/2023 |
4
| Kunkel Lori Anne (Director) has filed a Form 4 on Nurix Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $9.44, valued at
$236k
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2022 |
4
| Kunkel Lori Anne (Director) has filed a Form 4 on Nurix Therapeutics, Inc.|
Txns:
| Granted 17,500 options to buy
@ $10.39, valued at
$181.8k
|
|
| 01/31/2022 |
4
| Kunkel Lori Anne (Director) has filed a Form 4 on CURIS INC|
Txns:
| Granted 85,000 options to buy
@ $3.19, valued at
$271.2k
|
|
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2021 |
4
| Kunkel Lori Anne (Director) has filed a Form 4 on Nurix Therapeutics, Inc.|
Txns:
| Granted 17,500 options to buy
@ $27.38, valued at
$479.2k
|
|
| 01/29/2021 |
4
| Kunkel Lori Anne (Director) has filed a Form 4 on CURIS INC|
Txns:
| Granted 33,000 options to buy
@ $9.14, valued at
$301.6k
|
|
| 07/23/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/10/2020 |
4
| Kunkel Lori Anne (Director) has filed a Form 4 on Oric Pharmaceuticals, Inc.|
Txns:
| Granted 28,515 options to buy
@ $35.92, valued at
$1M
|
|
| 06/10/2020 |
3
| Kunkel Lori Anne (Director) has filed a Form 3 on Oric Pharmaceuticals, Inc. |
| 03/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/31/2019 |
4
| Kunkel Lori Anne (Director) has filed a Form 4 on Tocagen Inc|
Txns:
| Granted 20,000 options to buy
@ $4.22, valued at
$84.4k
|
|
| 02/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/15/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/25/2019 |
4
| Kunkel Lori Anne (Director) has filed a Form 4 on CURIS INC|
Txns:
| Sold 14,800 shares
@ $1.0528, valued at
$15.6k
|
|
| 01/23/2019 |
4
| Kunkel Lori Anne (Director) has filed a Form 4 on CURIS INC|
Txns:
| Granted 180,000 options to buy
@ $1.16, valued at
$208.8k
|
|
| 10/03/2018 |
4
| Kunkel Lori Anne (Director) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 4,500 shares
@ $170.1958, valued at
$765.9k
Sold 500 shares
@ $171.896, valued at
$85.9k
Exercised 5,000 options to buy
@ $3.648, valued at
$18.2k
|
|
| 06/25/2018 |
4
| Kunkel Lori Anne (Director) has filed a Form 4 on Tocagen Inc|
Txns:
| Granted 20,000 options to buy
@ $8.98, valued at
$179.6k
|
|
| 06/18/2018 |
4
| Kunkel Lori Anne (Director) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 28,440 shares
@ $180.2751, valued at
$5.1M
Sold 2,411 shares
@ $181.4783, valued at
$437.5k
Sold 1,541 shares
@ $182.3467, valued at
$281k
Sold 1,235 shares
@ $175.6434, valued at
$216.9k
Sold 5,601 shares
@ $177.1217, valued at
$992.1k
Sold 4 shares
@ $177.79, valued at
$711.2
Exercised 27,343 options to buy
@ $3.648, valued at
$99.7k
Exercised 3,096 options to buy
@ $20.91, valued at
$64.7k
Exercised 1,953 options to buy
@ $24.18, valued at
$47.2k
|
|
| 06/14/2018 |
4
| Kunkel Lori Anne (Director) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Granted 8,750 options to buy
@ $180.98, valued at
$1.6M
|
|
| 04/24/2018 |
4
| Kunkel Lori Anne (Director) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 900 shares
@ $131.9772, valued at
$118.8k
Sold 4,000 shares
@ $132.8097, valued at
$531.2k
Sold 100 shares
@ $133.6, valued at
$13.4k
|
|
| 01/24/2018 |
4
| Kunkel Lori Anne (Director) has filed a Form 4 on CURIS INC|
Txns:
| Granted 185,000 shares
@ $0 |
|
| 11/06/2017 |
4
| Kunkel Lori Anne (Director) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 1,800 shares
@ $84.1494, valued at
$151.5k
Sold 2,800 shares
@ $85.2109, valued at
$238.6k
Sold 400 shares
@ $86.2775, valued at
$34.5k
|
|
| 08/23/2017 |
4
| Kunkel Lori Anne (Director) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 10,000 shares
@ $75.1731, valued at
$751.7k
|
|
| 06/23/2017 |
4
| Kunkel Lori Anne (Director) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Granted 11,000 options to buy
@ $78.58, valued at
$864.4k
|
|
| 04/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/12/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 03/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/14/2016 |
4
| Kunkel Lori Anne (Director) has filed a Form 4 on CURIS INC|
Txns:
| Granted 25,000 options to buy
@ $3.36, valued at
$84k
|
|
| 11/14/2016 |
3
| Kunkel Lori Anne (Director) has filed a Form 3 on CURIS INC |
| 06/13/2016 |
4
| Kunkel Lori Anne (Director) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Granted 7,812 options to buy
@ $24.18, valued at
$188.9k
|
|
| 07/30/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/01/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|